Skip to main content

Ten die in Chinese pharma plant accident

Ten workers were killed in an accident at a pharmaceutical intermediates and APIs plant in China’s Shandong province on 15 April, it has emerged. This was the second fatal industrial accident at a chemicals-related plant in China within the space of a month.

Envigo and Covance in asset swap

Envigo’s Research Models Services business is to acquire the Research Products business of LabCorp’s Covance subsidiary, becoming a pure-play research models and services business. As part of the same transaction, Covance is also acquiring Envigo’s non-clinical research services business, expanding its services in that field.

Authorities close China blast park

Repercussions are continuing from the blast at the Chenjiagang Chemical Industry Park in Xiangshui, China, on 21 March, which killed 78 people and injured over 600 more.

Merck to spend €1 billion more at Darmstadt

The management and joint works council of Merck KGaA have made a comprehensive agreement about the main site in Darmstadt, Germany, with the stated aim of securing its future viability as a central science and technology hub and further expanding it.

AGC acquires in two fields

Japan’s AGC has completed the acquisition of Malgrat Pharma Chemicals (MPC), a maker of synthetic APIs based in Spain, from Boheringer Ingelheim.

Charles River to buy CiToxLab

Charles River Laboratories (CRL) has agreed to acquire CiToxLab in a €448 million merger that will create the largest player in the early stage CRO space for the pharmaceuticals industry. The deal is expected to close in Q2, subject to labour consultations, regulatory requirements and customary closing conditions.

Subscribe to Pharmaceuticals




AMRI banner advert